BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17043115)

  • 1. Effect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice.
    Stiefel U; Pultz NJ; Donskey CJ
    Antimicrob Agents Chemother; 2007 Jan; 51(1):372-5. PubMed ID: 17043115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice.
    Pultz MJ; Donskey CJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3044-5. PubMed ID: 17562802
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycin-resistant enterococci and extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae in mice.
    Pultz NJ; Stiefel U; Donskey CJ
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3513-6. PubMed ID: 16048971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice.
    Stiefel U; Pultz NJ; Helfand MS; Donskey CJ
    Infect Control Hosp Epidemiol; 2004 May; 25(5):373-9. PubMed ID: 15188841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a selective decontamination of the digestive tract regimen including parenteral cefepime on establishment of intestinal colonization with vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in mice.
    Paterson DL; Stiefel U; Donskey CJ
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2537-40. PubMed ID: 16801439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
    Hernández JR; Velasco C; Romero L; Martínez-Martínez L; Pascual A
    Int J Antimicrob Agents; 2006 Nov; 28(5):457-9. PubMed ID: 17008066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.
    Mody RM; Erwin DP; Summers AM; Carrero HA; Selby EB; Ewell AJ; Moran KA
    Ann Clin Microbiol Antimicrob; 2007 Jun; 6():6. PubMed ID: 17553151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy.
    DiNubile MJ; Friedland IR; Chan CY; Motyl MR; Giezek H; McCarroll K; Shivaprakash M; Quinn JP; Weinstein RA; Chow JW
    Diagn Microbiol Infect Dis; 2007 Aug; 58(4):491-4. PubMed ID: 17509789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
    Pillay T; Pillay DG; Adhikari M; Sturm AW
    Am J Perinatol; 1998 Jan; 15(1):47-51. PubMed ID: 9475688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Moczygemba LR; Frei CR; Burgess DS
    Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage therapy with tigecycline for recurrent infection caused by ertapenem-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
    Chen PL; Yan JJ; Wu CJ; Lee HC; Chang CM; Lee NY; Ko NY; Wang LR; Shih HI; Lee CC; Ko WC
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):312-4. PubMed ID: 20846813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of gastric acid production by proton pump inhibitor treatment facilitates colonization of the large intestine by vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in clindamycin-treated mice.
    Stiefel U; Rao A; Pultz MJ; Jump RL; Aron DC; Donskey CJ
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3905-7. PubMed ID: 16940078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures.
    Landman D; Salvani JK; Bratu S; Quale J
    J Clin Microbiol; 2005 Nov; 43(11):5639-41. PubMed ID: 16272497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Fidaxomicin versus Vancomycin on Susceptibility to Intestinal Colonization with Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice.
    Deshpande A; Hurless K; Cadnum JL; Chesnel L; Gao L; Chan L; Kundrapu S; Polinkovsky A; Donskey CJ
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3988-93. PubMed ID: 27090175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
    Burgess DS; Hall RG
    Diagn Microbiol Infect Dis; 2004 May; 49(1):41-6. PubMed ID: 15135499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of parenteral antibiotic administration on establishment of intestinal colonization in mice by Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.
    Hoyen CK; Pultz NJ; Paterson DL; Aron DC; Donskey CJ
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3610-2. PubMed ID: 14576127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal effect of ceftriaxone versus imipenem plus cilastatin in bronchial secretion.
    Fraschini F; Scaglione F; Cogo R; Casali W; Falchi M; Gattei G
    Chemotherapy; 1988; 34 Suppl 1():3-15. PubMed ID: 3073044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing.
    Tenover FC; Kalsi RK; Williams PP; Carey RB; Stocker S; Lonsway D; Rasheed JK; Biddle JW; McGowan JE; Hanna B
    Emerg Infect Dis; 2006 Aug; 12(8):1209-13. PubMed ID: 16965699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy.
    Mammina C; Bonura C; Aleo A; Fasciana T; Brunelli T; Pesavento G; Degl'Innocenti R; Nastasi A
    Int J Antimicrob Agents; 2012 Jun; 39(6):543-5. PubMed ID: 22534506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.